ModivCare Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MODVQ research report →
Range $6 – $30
Price Chart
About the company
ModivCare Inc. is a healthcare services firm that leverages technology to deliver a comprehensive array of integrated supportive care solutions. It caters to both public and private insurers, as well as directly to individuals requiring assistance.
- CEO
- L. Heath Sampson
- IPO
- 2003
- Employees
- 23,675
- HQ
- Denver, CO, US
Get TickerSpark's AI analysis on MODVQ
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $215.31K
- P/E
- -0.00
- Fwd P/E
- 0.02
- PEG
- 0.00
- P/S
- 0.00
- P/B
- -0.00
- EV/EBITDA
- -5.35
- Div Yield
- 0.00%
- Gross Margin
- 13.00%
- Op Margin
- -1.09%
- Net Margin
- -21.47%
- ROE
- 135.85%
- ROIC
- -1.89%
Latest fiscal year · YoY change
- Revenue
- $2.79B+1.3%
- Gross Profit
- $420.37M-5.9%
- Op Income
- $-92,787,000
- Net Income
- $-201,278,000+1.6%
- EPS
- $-14.14+2.0%
- OCF Growth
- +92.3%
- FCF Growth
- +72.8%
- 52W High
- $6.24
- 52W Low
- $0.00
- 50D MA
- $0.02
- 200D MA
- $1.09
- Beta
- -0.13
- RSI (14)
- 46
- Avg Volume
- 21.23K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
ModivCare said Q1 was about stabilizing the business: revenue and cash flow were pressured, but management highlighted contract wins, automation gains, and a plan to simplify costs and delever over time.· May 8, 2025
- Revenue was $650.7 million, down 5% year over year and 2% sequentially; adjusted EBITDA was $32.6 million, roughly flat year over year, and adjusted net loss was $24.5 million or negative $1.71 per share.
- NEMT signed two new Medicaid managed care contracts worth about $52 million in annual contract value, while also losing a $15 million annual revenue regional contract.
- Management launched a company-wide G&A reduction plan targeting about $25 million of annualized savings, mostly from labor in corporate/shared services.
- Cash flow was weak in Q1, with free cash flow at negative $86.2 million and net contracts receivable up to $109 million, but the company collected about $30 million in April ahead of schedule.
- Management said it is not issuing formal 2025 guidance, but expects cash flow to improve as contract structures reset, working capital needs come down, and cost cuts flow through.
Q1 revenue was $650.7 million, down 5% year over year and 2% sequentially. Net loss was $50.4 million versus $22.3 million a year ago, driven mainly by higher interest expense of $38.8 million. Adjusted net loss was $24.5 million, or negative $1.71 per share, and adjusted EBITDA was $32.6 million, essentially flat year over year but down sequentially. Segment highlights included NEMT revenue of $449 million, down 6% year over year, PCS revenue of $181.8 million, and monitoring revenue of $18.1 million. Free cash flow was negative $86.2 million, cash ended at $116 million, and the revolver was fully drawn at $269 million. Management did not provide formal 2025 guidance, but said it expects meaningful improvement in cash flow generation as the year progresses, with working-capital needs declining and the majority of contract structure changes flowing through by 2026.
Heath Sampson framed the quarter around five enterprise objectives: grow and retain customers, digitize care access, simplify the operating model, improve capital efficiency, and deliver supportive care. He sounded constructive on execution, pointing to two new NEMT wins, strong digital adoption, and multiple operating changes that he said should make the business more scalable and less capital intensive. He also emphasized urgency around deleveraging and said the strategic alternatives process is being run to maximize value for stakeholders, even if timing remains disciplined.
There was no separate CFO prepared commentary; Sampson covered the financials and capital plan. He said the company is taking a company-wide G&A reduction action targeting about $25 million of annualized savings, with the majority coming from labor in corporate and shared services. On capital, he highlighted the January capital raise, $30 million collected in April from a large NCO receivable about a month early, and a shift in some NEMT contracts to faster-settling structures that should improve collection predictability. He also noted Q1 net contracts receivable of $109 million, cash of $116 million, a fully drawn $269 million revolver, and free cash flow of negative $86.2 million due to working-capital build, contract transitions, and higher interest expense.
Analysts focused mainly on cash flow, the timing of debt payments, and whether the strategic alternatives review could produce a transaction this year. Management said cash flow should be assessed on an annual basis because debt payments are lumpy, and while it would not give a quarter-by-quarter forecast, it expects meaningful improvement as cost cuts, automation, and working-capital changes take hold. On receivables, management said the increase was driven by shared-risk contract structures rather than revenue weakness, and on the lost NEMT contract it said the customer consolidated with another vendor, which it viewed as a reminder to improve account management rather than a broad trend.
The positive case from the call is that ModivCare is still winning material new contracts while improving service metrics and digitization. Management pointed to 36.1% self-service call-to-trip volume, 1 million-plus digital transactions, lower complaints, and a $25 million G&A reduction plan, all of which could support margin and cash flow if execution holds.
The main risks are still visible in the numbers: revenue fell, free cash flow was deeply negative, receivables remain elevated, and interest expense nearly doubled because the revolver is fully drawn. Management also acknowledged contract attrition, continued pricing resets, and that some margin normalization could pressure PCS in Q2 as wage changes phase in.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 84.6%
- Shares Outstanding
- 14.35M
- Float Shares
- 12.14M
Buy/sell ratio 1.29. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 31, 25 | Berstler Chelsey | other | 807 |
| Apr 24, 25 | Silvers Daniel B. | other | 0 |
| Mar 7, 25 | Mounts Gonzales David | other | 0 |
| Mar 7, 25 | Cunningham Alexander R. | other | 0 |
| Feb 10, 25 | Russell Erin L | other | 0 |
| Feb 3, 25 | AI Catalyst Fund, LP | buy | 187,500 |
| Jan 31, 25 | AI Catalyst Fund, LP | buy | 187,500 |
| Jan 30, 25 | AI Catalyst Fund, LP | buy | 45,000 |
| Jan 23, 25 | AI Catalyst Fund, LP | other | 0 |
| Jan 14, 25 | Coliseum Capital Management, LLC | buy | 330,046 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our MODVQ coverage
Recent articles, reports, and earnings notes.
No research on MODVQ yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate MODVQ report →Stone House Investment Management, LLC Sells 1,390 Shares of ModivCare Inc (MODVQ)
gurufocus.com · Jan 21
Modivcare Successfully Completes Financial Restructuring, Reducing Debt by More Than 85%
businesswire.com · Dec 29
Modivcare Announces Confirmation of Restructuring Plan
businesswire.com · Dec 12
Modivcare Receives Nasdaq Delisting Notice Following Chapter 11 Filing
businesswire.com · Aug 22
Modivcare Enters into Comprehensive Restructuring Agreement to Strengthen its Future, Reduce Debt and Inject Capital
businesswire.com · Aug 20
MODIVCARE ALERT: Bragar Eagel & Squire, P.C. Continues Investigating ModivCare, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
globenewswire.com · Jul 31
Modivcare Regains Compliance with Nasdaq Continued Listing Standard
businesswire.com · Jul 10
Modivcare Celebrates Over a Decade of Serving Suffolk Community Member
businesswire.com · Jun 25
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.